Middlefield Income Plus II Corp T.MIP

Message from the Prez &CEO

[dblanc]

Sent an email to the prez.. responded within minutes, I guess he is watching too: """Thank you for your e-mail and support. As you know, we do not control what investors do with their shares. What I can say is that Mistral is doing very well. As announced today, we will be at BioFinance this week with numerous meetings during the conference. We have recently announced the acquisition of CuraMedica and I don’t think the market understands this transaction. BioFinance is an excellent opportunity to explain more. It’s quite exciting for the company as it should provide Mistral with product revenues before the end of the year. This will help reduce burn rate and constitute our first step in direct product marketing. Dalal Manoli is joining us and provides Mistral with a top pharma executive. We have known each other for many years. We hope to make more deals like this one and use our pipeline products to make quid pro quo deals. With CuraMedica, Mistral will become one of the few Canadian biopharmaceutical companies with a product on the market. Feel free to give me call if you need more info. I am always available to talk to shareholders. Sincerely, Bertrand Bertrand F. Bolduc, B.Pharm., MBA President & CEO Mistral Pharma Inc. TSX Venture: MIP 1717, Trans-Canada Dorval, Québec, Canada, H9P 1J1 Tel: [phone] # 2224 Mobile: [phone] Fax: [phone] [e-mail] www.mistralpharma.com -------------------------------------------------------------------------------- From: Sent: 23 avril 2007 18:07 To: Bertrand Bolduc Subject: MIP Bertrand, is there something happening with your company? Stock has been dumping something fierce today, should we be worried?